In-vivo Imaging companies

Key In-Vivo Imaging Market Players:

The international in-vivo imaging market is readily characterized by a combination of advanced small-scale organizations and entrenched multinational conglomerates. Besides, notable strategies include a robust focus on research and developmental activities to pioneer hybrid multimodal systems and AI-powered analytics. Moreover, key players are increasingly integrating tactical acquisitions and partnerships to extend their geographic footprint and technological portfolios, particularly in highly developed nations. Meanwhile, an effective transition towards service-specific business models, such as long-lasting maintenance contracts, along with analytics-as-a-service, are also positively impacting the market’s growth across different nations.

Here is a list of key players operating in the global market:

• Siemens Healthineers (Germany)
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis
• GE HealthCare (U.S.)
• PerkinElmer, Inc. (U.S.)
• Bruker Corporation (U.S.)
• Medtronic plc (Ireland)
• Koninklijke Philips N.V. (Netherlands)
• Miltenyi Biotec (Germany)
• Agilent Technologies, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Mindray Medical International Ltd. (China)
• Esaote S.p.A. (Italy)
• Cardinal Health, Inc. (U.S.)
• Curium Pharma (U.S./France)
• Lantheus Holdings, Inc. (U.S.)
• Trivitron Healthcare (India)
• Magnetic Insight, Inc. (U.S.)
• Advantage Medical Pty Ltd. (Australia)
• Samsung Medison (South Korea)
• United Imaging Healthcare (China)
• BCF Technology Ltd. (UK)